EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Incremental Predictive Value of Dynamic Platelet‐to‐Lymphocyte Ratio Beyond ESR and CRP for Glucocorticoid Sparing in Rheumatoid Arthritis: A Multi‐Center Retrospective Cohort Study

Jyun-Pei Jhou iD, Yin-Hui Hou iD, Yu-Sheng Chang iD, Wan-Chen Shen iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-11 · 46 (11)

DOI: 10.1002/phar.70209 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 22.10.2026. Verfasst von Jyun-Pei Jhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Glucocorticoids, Antirheumatic Agents, Blood Platelets. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify independent predictors of sustained glucocorticoid (GC) sparing in patients with rheumatoid arthritis (RA) initiating biological or targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs), specifically we evaluated whether the longitudinal platelet‐to‐lymphocyte ratio (ΔPLR) trajectory provides superior prognostic value compared to conventional measurements.

Methods

This multicenter retrospective study analyzed 264 patients from the Taipei Medical University Clinical Research Database. Sparing success was defined as achieving predefined dose reduction targets at month 6 and maintaining stability for ≥ 12 weeks. Candidate predictors were screened using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic and Cox proportional hazards modeling. Clinical utility was assessed using “rescue rate” analysis.

Results

Sustained GC sparing was achieved by 139 (52.7%) patients. First‐line b/tsDMARD initiation was the strongest predictor (adjusted odds ratio [aOR] 4.23, p < 0.001) of GC‐sparing success. Although static baseline inflammatory markers were non‐predictive, every 10% reduction in 6‐month ΔPLR independently increased success odds (aOR 1.05 [inverted from 0.95 per 10% increase], p = 0.009) and significantly accelerated the sparing rate (hazard ratio [HR] 1.02, p = 0.021). Conversely, concomitant nonsteroidal antiinflammatory drug use hindered success. Notably, incorporating ΔPLR into the predictive model “rescued” 16.5% of unrecognized candidates for de‐escalation—patients capable of successful GC sparing who were misclassified by standard clinical models.

Conclusion

Although static baseline inflammatory markers are nonpredictive, 6‐month ΔPLR offers significant incremental prognostic value beyond conventional erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP). By identifying 16.5% of viable candidates overlooked by standard assessments, dynamic PLR monitoring offers a potential strategy to optimize precision steroid de‐escalation in RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidGlucocorticoidsAntirheumatic AgentsBlood PlateletsLymphocytesHumansRetrospective StudiesFemaleMaleC-Reactive ProteinMiddle AgedPredictive Value of TestsBlood SedimentationAgedPlatelet CountPrognosisLymphocyte CountCohort Studies

Stichwörter der Autor:innen

biological or targeted synthetic DMARDsglucocorticoid sparingplatelet‐to‐lymphocyte ratio (PLR)predictive modelrheumatoid arthritis

Substanzen

GlucocorticoidsAntirheumatic AgentsC-Reactive Protein

Autor:innen und Institutionen

  • Department of Pharmacy, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.

ORCID-Profile: Jyun-Pei Jhou, Yin-Hui Hou, Yu-Sheng Chang, Wan-Chen Shen

Förderung

  • Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare

Zitieren

APA

Jhou, J. P., Hou, Y. H., Chang, Y. S., & Shen, W. C. (2026). Incremental Predictive Value of Dynamic Platelet‐to‐Lymphocyte Ratio Beyond ESR and CRP for Glucocorticoid Sparing in Rheumatoid Arthritis: A Multi‐Center Retrospective Cohort Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(11). https://doi.org/10.1002/phar.70209

Vancouver

Jhou JP, Hou YH, Chang YS, Shen WC. Incremental Predictive Value of Dynamic Platelet‐to‐Lymphocyte Ratio Beyond ESR and CRP for Glucocorticoid Sparing in Rheumatoid Arthritis: A Multi‐Center Retrospective Cohort Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(11). doi:10.1002/phar.70209

BibTeX
@article{Jhou2026,
  author = {Jhou, Jyun-Pei and Hou, Yin-Hui and Chang, Yu-Sheng and Shen, Wan-Chen},
  title = {Incremental Predictive Value of Dynamic Platelet‐to‐Lymphocyte Ratio Beyond ESR and CRP for Glucocorticoid Sparing in Rheumatoid Arthritis: A Multi‐Center Retrospective Cohort Study},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1002/phar.70209}
}
Kostenlos starten →